April 12, 2022 Comments Off on New patent for Astrazeneca drug BRILINTA Posted in: Patent Added Annual Drug Patent Expirations for BRILINTA Brilinta is a drug marketed by Astrazeneca and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent for Astrazeneca drug BRILINTA appeared first …
April 12, 2022 Comments Off on New patent for Amicus Therap drug GALAFOLD Posted in: Patent Added Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are twenty-nine patents protecting this drug. This drug…
The post New patent for Amicus Therap drug GALAFOLD appeared first on…
